Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Recurrent Ischemia After Thrombolysis: Importance of Associated Clinical Findings

Identifieur interne : 00C969 ( Main/Exploration ); précédent : 00C968; suivant : 00C970

Recurrent Ischemia After Thrombolysis: Importance of Associated Clinical Findings

Auteurs : Amadeo Betriu [Espagne] ; Robert M. Califf [États-Unis] ; Xavier Bosch [Espagne] ; Alan Guerci [États-Unis] ; Amanda L. Stebbins [États-Unis] ; N. Alejandro Barbagelata [Argentine] ; Philip E. Aylward [Australie] ; Alec Vahanian [France] ; Frans Van De Werf [Belgique] ; Eric J. Topol [États-Unis]

Source :

RBID : ISTEX:C265F2744A61FD8C5B2792DA56D78AC3C7C2A525

Descripteurs français

English descriptors

Abstract

Abstract: Objectives. We sought to assess the incidence and clinical relevance of examination data to recurrent ischemia within an international randomized trial. Background. Ischemic symptoms commonly recur after thrombolysis for acute myocardial infarction. Methods. Patients (n = 40,848) were prospectively evaluated for recurrent angina and transient electrocardiographic (ECG) or hemodynamic changes. Five groups were developed: Group 1, patients with no signs or symptoms of recurrent ischemia; Group 2, patients with angina only; Group 3, patients with angina and ST segment changes; Group 4, patients with angina and hemodynamic abnormalities; and Group 5, patients with angina, ST segment changes and hemodynamic abnormalities. Baseline clinical and outcome variables were compared among the five groups. Results. Group 1 comprised 32,717 patients, and Groups 2 to 5 comprised 20% of patients (4,488 in Group 2; 3,021 in Group 3; 337 in Group 4; and 285 in Group 5). Patients with recurrent ischemia were more often female, had more cardiovascular risk factors and less often received intravenous heparin. Significantly more extensive and more severe coronary disease, antianginal treatment, angioplasty and coronary bypass surgery were observed as a function of ischemic severity. The 30-day reinfarction rate was 1.6% in Group 1, 6.5% in Group 2, 21.7% in Group 3, 13.1% in Group 4 and 36.5% in Group 5 (p < 0.0001); in contrast, the 30-day mortality rate was significantly lower (p < 0.0001) in Groups 1, 2 and 3 (6.6%, 5.4% and 7.7%, respectively) than in Groups 4 and 5 (21.8% and 29.1%). Conclusions. Postinfarction angina greatly increases the risk of reinfarction, especially when accompanied by transient ECG changes. However, mortality is markedly increased only in the presence of concomitant hemodynamic abnormalities.

Url:
DOI: 10.1016/S0735-1097(97)00428-2


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Recurrent Ischemia After Thrombolysis: Importance of Associated Clinical Findings</title>
<author>
<name sortKey="Betriu, Amadeo" sort="Betriu, Amadeo" uniqKey="Betriu A" first="Amadeo" last="Betriu">Amadeo Betriu</name>
</author>
<author>
<name sortKey="Califf, Robert M" sort="Califf, Robert M" uniqKey="Califf R" first="Robert M." last="Califf">Robert M. Califf</name>
</author>
<author>
<name sortKey="Bosch, Xavier" sort="Bosch, Xavier" uniqKey="Bosch X" first="Xavier" last="Bosch">Xavier Bosch</name>
</author>
<author>
<name sortKey="Guerci, Alan" sort="Guerci, Alan" uniqKey="Guerci A" first="Alan" last="Guerci">Alan Guerci</name>
</author>
<author>
<name sortKey="Stebbins, Amanda L" sort="Stebbins, Amanda L" uniqKey="Stebbins A" first="Amanda L." last="Stebbins">Amanda L. Stebbins</name>
</author>
<author>
<name sortKey="Barbagelata, N Alejandro" sort="Barbagelata, N Alejandro" uniqKey="Barbagelata N" first="N. Alejandro" last="Barbagelata">N. Alejandro Barbagelata</name>
</author>
<author>
<name sortKey="Aylward, Philip E" sort="Aylward, Philip E" uniqKey="Aylward P" first="Philip E." last="Aylward">Philip E. Aylward</name>
</author>
<author>
<name sortKey="Vahanian, Alec" sort="Vahanian, Alec" uniqKey="Vahanian A" first="Alec" last="Vahanian">Alec Vahanian</name>
</author>
<author>
<name sortKey="Van De Werf, Frans" sort="Van De Werf, Frans" uniqKey="Van De Werf F" first="Frans" last="Van De Werf">Frans Van De Werf</name>
</author>
<author>
<name sortKey="Topol, Eric J" sort="Topol, Eric J" uniqKey="Topol E" first="Eric J." last="Topol">Eric J. Topol</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C265F2744A61FD8C5B2792DA56D78AC3C7C2A525</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1016/S0735-1097(97)00428-2</idno>
<idno type="url">https://api.istex.fr/document/C265F2744A61FD8C5B2792DA56D78AC3C7C2A525/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002419</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002419</idno>
<idno type="wicri:Area/Istex/Curation">002419</idno>
<idno type="wicri:Area/Istex/Checkpoint">002328</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002328</idno>
<idno type="wicri:doubleKey">0735-1097:1998:Betriu A:recurrent:ischemia:after</idno>
<idno type="wicri:Area/Main/Merge">00DA06</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:98-0075450</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">006821</idno>
<idno type="wicri:Area/PascalFrancis/Curation">006841</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">006284</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">006284</idno>
<idno type="wicri:doubleKey">0735-1097:1998:Betriu A:recurrent:ischemia:after</idno>
<idno type="wicri:Area/Main/Merge">00DB71</idno>
<idno type="wicri:Area/Main/Curation">00C969</idno>
<idno type="wicri:Area/Main/Exploration">00C969</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Recurrent Ischemia After Thrombolysis: Importance of Associated Clinical Findings</title>
<author>
<name sortKey="Betriu, Amadeo" sort="Betriu, Amadeo" uniqKey="Betriu A" first="Amadeo" last="Betriu">Amadeo Betriu</name>
<affiliation></affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr" wicri:curation="lc">Espagne</country>
<wicri:regionArea>Hospital Clinic, University of Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Califf, Robert M" sort="Califf, Robert M" uniqKey="Califf R" first="Robert M." last="Califf">Robert M. Califf</name>
<affiliation wicri:level="2">
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Duke University Medical Center, Durham, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bosch, Xavier" sort="Bosch, Xavier" uniqKey="Bosch X" first="Xavier" last="Bosch">Xavier Bosch</name>
<affiliation wicri:level="3">
<country xml:lang="fr" wicri:curation="lc">Espagne</country>
<wicri:regionArea>Hospital Clinic, University of Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Guerci, Alan" sort="Guerci, Alan" uniqKey="Guerci A" first="Alan" last="Guerci">Alan Guerci</name>
<affiliation wicri:level="2">
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>St. Francis Hospital, Roslyn, New York</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Stebbins, Amanda L" sort="Stebbins, Amanda L" uniqKey="Stebbins A" first="Amanda L." last="Stebbins">Amanda L. Stebbins</name>
<affiliation wicri:level="2">
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Duke University Medical Center, Durham, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Barbagelata, N Alejandro" sort="Barbagelata, N Alejandro" uniqKey="Barbagelata N" first="N. Alejandro" last="Barbagelata">N. Alejandro Barbagelata</name>
<affiliation wicri:level="1">
<country xml:lang="fr" wicri:curation="lc">Argentine</country>
<wicri:regionArea>Fundación Favaloro, Buenos Aires</wicri:regionArea>
<wicri:noRegion>Buenos Aires</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Aylward, Philip E" sort="Aylward, Philip E" uniqKey="Aylward P" first="Philip E." last="Aylward">Philip E. Aylward</name>
<affiliation wicri:level="1">
<country xml:lang="fr" wicri:curation="lc">Australie</country>
<wicri:regionArea>Flinders Medical Centre, Bedford Park, South Australia</wicri:regionArea>
<wicri:noRegion>South Australia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Vahanian, Alec" sort="Vahanian, Alec" uniqKey="Vahanian A" first="Alec" last="Vahanian">Alec Vahanian</name>
<affiliation wicri:level="3">
<country xml:lang="fr" wicri:curation="lc">France</country>
<wicri:regionArea>Hospital Tenon, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Van De Werf, Frans" sort="Van De Werf, Frans" uniqKey="Van De Werf F" first="Frans" last="Van De Werf">Frans Van De Werf</name>
<affiliation wicri:level="1">
<country xml:lang="fr" wicri:curation="lc">Belgique</country>
<wicri:regionArea>Universitaire Ziekenhuizen Leuven, Leuven</wicri:regionArea>
<wicri:noRegion>Leuven</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Topol, Eric J" sort="Topol, Eric J" uniqKey="Topol E" first="Eric J." last="Topol">Eric J. Topol</name>
<affiliation wicri:level="2">
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Cleveland Clinic Foundation, Cleveland, Ohio</wicri:regionArea>
<placeName>
<region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of the American College of Cardiology</title>
<title level="j" type="abbrev">JAC</title>
<idno type="ISSN">0735-1097</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1998">1998</date>
<biblScope unit="volume">31</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="94">94</biblScope>
<biblScope unit="page" to="102">102</biblScope>
</imprint>
<idno type="ISSN">0735-1097</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0735-1097</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>ACE</term>
<term>AHCPR</term>
<term>Abnormality</term>
<term>Angina</term>
<term>Angina pectoris</term>
<term>Angiographic</term>
<term>Angiography</term>
<term>Angioplasty</term>
<term>Baseline</term>
<term>Baseline characteristics</term>
<term>Betriu</term>
<term>CK</term>
<term>Cardiogenic shock</term>
<term>Cardiol</term>
<term>Chest pain</term>
<term>Clinical outcomes</term>
<term>Coll</term>
<term>Coll cardiol</term>
<term>Coronary artery</term>
<term>ECG</term>
<term>Early angina</term>
<term>Early postinfarction angina</term>
<term>Engl</term>
<term>Exploration</term>
<term>Fibrinolytic</term>
<term>GUSTO-I</term>
<term>Health care policy</term>
<term>Hemodynamic</term>
<term>Hemodynamic abnormalities</term>
<term>Hemodynamic impairment</term>
<term>Heparin</term>
<term>Human</term>
<term>Incidence</term>
<term>Infarct</term>
<term>Infarction</term>
<term>Intravenous</term>
<term>Intravenous heparin</term>
<term>Ischemia</term>
<term>Ischemic</term>
<term>Ischemic symptoms</term>
<term>Jacc</term>
<term>January</term>
<term>MI</term>
<term>Median</term>
<term>Myocardial</term>
<term>Myocardial infarction</term>
<term>Myocardium</term>
<term>Ndings</term>
<term>Partial thromboplastin time</term>
<term>Patient group</term>
<term>Pectoris</term>
<term>Physical examination</term>
<term>Postinfarction</term>
<term>Postinfarction angina</term>
<term>Prognostic</term>
<term>Randomized</term>
<term>Recurrent</term>
<term>Recurrent angina</term>
<term>Recurrent angina category group</term>
<term>Recurrent ischemia</term>
<term>Reinfarction</term>
<term>Relapse</term>
<term>Segment changes</term>
<term>Statistical study</term>
<term>Study group</term>
<term>Study patients</term>
<term>TIMI</term>
<term>Thrombolysis</term>
<term>Thrombolysis jacc</term>
<term>Thrombolytic</term>
<term>Thrombolytic therapy</term>
<term>Unstable angina</term>
<term>aPTT</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Etude statistique</term>
<term>Exploration</term>
<term>Fibrinolytique</term>
<term>Homme</term>
<term>Incidence</term>
<term>Infarctus</term>
<term>Ischémie</term>
<term>Myocarde</term>
<term>Récidive</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Abnormality</term>
<term>Angina</term>
<term>Angina pectoris</term>
<term>Angiographic</term>
<term>Angiography</term>
<term>Angioplasty</term>
<term>Baseline</term>
<term>Baseline characteristics</term>
<term>Betriu</term>
<term>Cardiogenic shock</term>
<term>Cardiol</term>
<term>Chest pain</term>
<term>Clinical outcomes</term>
<term>Coll</term>
<term>Coll cardiol</term>
<term>Coronary artery</term>
<term>Early angina</term>
<term>Early postinfarction angina</term>
<term>Engl</term>
<term>Health care policy</term>
<term>Hemodynamic</term>
<term>Hemodynamic abnormalities</term>
<term>Hemodynamic impairment</term>
<term>Heparin</term>
<term>Infarction</term>
<term>Intravenous</term>
<term>Intravenous heparin</term>
<term>Ischemia</term>
<term>Ischemic</term>
<term>Ischemic symptoms</term>
<term>Jacc</term>
<term>January</term>
<term>Median</term>
<term>Myocardial</term>
<term>Myocardial infarction</term>
<term>Ndings</term>
<term>Partial thromboplastin time</term>
<term>Patient group</term>
<term>Pectoris</term>
<term>Physical examination</term>
<term>Postinfarction</term>
<term>Postinfarction angina</term>
<term>Prognostic</term>
<term>Randomized</term>
<term>Recurrent</term>
<term>Recurrent angina</term>
<term>Recurrent angina category group</term>
<term>Recurrent ischemia</term>
<term>Reinfarction</term>
<term>Segment changes</term>
<term>Study group</term>
<term>Study patients</term>
<term>Thrombolysis</term>
<term>Thrombolysis jacc</term>
<term>Thrombolytic</term>
<term>Thrombolytic therapy</term>
<term>Unstable angina</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Objectives. We sought to assess the incidence and clinical relevance of examination data to recurrent ischemia within an international randomized trial. Background. Ischemic symptoms commonly recur after thrombolysis for acute myocardial infarction. Methods. Patients (n = 40,848) were prospectively evaluated for recurrent angina and transient electrocardiographic (ECG) or hemodynamic changes. Five groups were developed: Group 1, patients with no signs or symptoms of recurrent ischemia; Group 2, patients with angina only; Group 3, patients with angina and ST segment changes; Group 4, patients with angina and hemodynamic abnormalities; and Group 5, patients with angina, ST segment changes and hemodynamic abnormalities. Baseline clinical and outcome variables were compared among the five groups. Results. Group 1 comprised 32,717 patients, and Groups 2 to 5 comprised 20% of patients (4,488 in Group 2; 3,021 in Group 3; 337 in Group 4; and 285 in Group 5). Patients with recurrent ischemia were more often female, had more cardiovascular risk factors and less often received intravenous heparin. Significantly more extensive and more severe coronary disease, antianginal treatment, angioplasty and coronary bypass surgery were observed as a function of ischemic severity. The 30-day reinfarction rate was 1.6% in Group 1, 6.5% in Group 2, 21.7% in Group 3, 13.1% in Group 4 and 36.5% in Group 5 (p < 0.0001); in contrast, the 30-day mortality rate was significantly lower (p < 0.0001) in Groups 1, 2 and 3 (6.6%, 5.4% and 7.7%, respectively) than in Groups 4 and 5 (21.8% and 29.1%). Conclusions. Postinfarction angina greatly increases the risk of reinfarction, especially when accompanied by transient ECG changes. However, mortality is markedly increased only in the presence of concomitant hemodynamic abnormalities.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Argentine</li>
<li>Australie</li>
<li>Belgique</li>
<li>Espagne</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Caroline du Nord</li>
<li>Catalogne</li>
<li>Ohio</li>
<li>État de New York</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Barcelone</li>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="Espagne">
<region name="Catalogne">
<name sortKey="Betriu, Amadeo" sort="Betriu, Amadeo" uniqKey="Betriu A" first="Amadeo" last="Betriu">Amadeo Betriu</name>
</region>
<name sortKey="Bosch, Xavier" sort="Bosch, Xavier" uniqKey="Bosch X" first="Xavier" last="Bosch">Xavier Bosch</name>
</country>
<country name="États-Unis">
<region name="Caroline du Nord">
<name sortKey="Califf, Robert M" sort="Califf, Robert M" uniqKey="Califf R" first="Robert M." last="Califf">Robert M. Califf</name>
</region>
<name sortKey="Guerci, Alan" sort="Guerci, Alan" uniqKey="Guerci A" first="Alan" last="Guerci">Alan Guerci</name>
<name sortKey="Stebbins, Amanda L" sort="Stebbins, Amanda L" uniqKey="Stebbins A" first="Amanda L." last="Stebbins">Amanda L. Stebbins</name>
<name sortKey="Topol, Eric J" sort="Topol, Eric J" uniqKey="Topol E" first="Eric J." last="Topol">Eric J. Topol</name>
</country>
<country name="Argentine">
<noRegion>
<name sortKey="Barbagelata, N Alejandro" sort="Barbagelata, N Alejandro" uniqKey="Barbagelata N" first="N. Alejandro" last="Barbagelata">N. Alejandro Barbagelata</name>
</noRegion>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Aylward, Philip E" sort="Aylward, Philip E" uniqKey="Aylward P" first="Philip E." last="Aylward">Philip E. Aylward</name>
</noRegion>
</country>
<country name="France">
<region name="Île-de-France">
<name sortKey="Vahanian, Alec" sort="Vahanian, Alec" uniqKey="Vahanian A" first="Alec" last="Vahanian">Alec Vahanian</name>
</region>
</country>
<country name="Belgique">
<noRegion>
<name sortKey="Van De Werf, Frans" sort="Van De Werf, Frans" uniqKey="Van De Werf F" first="Frans" last="Van De Werf">Frans Van De Werf</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00C969 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00C969 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:C265F2744A61FD8C5B2792DA56D78AC3C7C2A525
   |texte=   Recurrent Ischemia After Thrombolysis: Importance of Associated Clinical Findings
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024